Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD

Clinical trial NCT00041483 · COMPLETED

Trial details

NCT number: NCT00041483
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Macular Degeneration

Start date: 2002-06-01
Primary completion: 2005-08-01
Enrollment: 530

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.